The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...
For some people, diet, and exercise are not enough to lose weight and keep it off. This is where weight loss medication, ...
The singer, 36, shared Instagram posts as her “FDA-approved” diet suppressor alter ego, complete with a cinched measuring tape and a faux drug box label Lizzo’s Halloween costume was ...
Oct 25 (Reuters) - The U.S. Food and Drug Administration has approved Iterum ... 2024 Healthcare & Pharmaceuticalscategory US FDA approves Johnson & Johnson's device for heart condition November ...
Back in April, the FDA approved Utility Therapeutics’ Pivya (pivmecillinam). The penicillin antibiotic underpinning Utility’s drug had never before been cleared in the U.S., despite being ...
Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again. The agency handed down a green light to the medtech giant’s all-in ...
Opens in a new tab or window The FDA approved oral sulopenem etzadroxil ... The most common adverse reactions in patients treated with the drug were diarrhea, nausea, vulvovaginal mycotic ...
The FDA notes that there are “multiple reasons” why nitrosamines like N-nitroso-duloxetine can end up in a medication. The source of nitrosamines can be related to the drug’s manufacturing ...
2 The Animal Medicinal Drug Use Clarification Act allows veterinarians to prescribe certain FDA-approved human or animal drugs to food-producing animals under defined conditions. These conditions ...
The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...
On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...
The FDA thumbs up for Abrysvo comes on top of its original approval in May of 2023 for those 60 and older. Three months later, the U.S. regulator also endorsed Abrysvo for women in weeks 32 ...